GeekWire logo

GeekWire

linkedin.com

GeekWire provides technology news, analysis, and resources for tech professionals, entrepreneurs, and enthusiasts. It covers developments in the technology industry, produces events and podcasts, and offers tools such as job boards and startup rankings to support the tech community. Its mission is to inform and connect people interested in technology and startups.

Facts

HQ
Seattle
Sectors
Online Audio and Video Media
Founded
2011
Employees
26
Registered name
GeekWire LLC Seattle business license
Founders
John Cook, Todd Bishop

Is this your organization? Claim it

Publication

  • Last published Oct 15

Authors & Editors

Abacus Bioscience Raises $4.4M for Novel Cancer Vaccine Technology Led by Ex-Seagen Executives

Abacus Bioscience, a University of Washington spinout led by former Seattle Genetics veterans, raised $4.4 million to develop a novel cancer vaccine approach targeting tumor antigens to stimulate a strong immune response. Despite historical skepticism about cancer vaccines, Abacus aims to advance a new technology that activates immune cells via antibody fragments linked to tumor antigens.

Microsoft Veteran Kevin Wang Launches Mentors in Tech Program Supporting Community College Students in Tech Careers

Kevin Wang, a Microsoft veteran, founded Mentors in Tech (MinT) to support community college students pursuing tech careers by connecting them with mentors and internships. The program has engaged nearly 500 students nationally, aiming to address workforce diversity and skill shortages by helping overlooked, underserved students gain entry into the tech industry.

Snapbar CEO Sam Eitzen Leads Pivot from Physical Booths to Global Virtual Photo Booth App, Doubling Revenue Multiple Times Since 2020

Snapbar, originally a physical photo booth company, pivoted during the COVID-19 pandemic to launch a virtual photo booth web application called Snapshot, which rapidly grew to become its primary revenue source and expanded its customer base globally. CEO Sam Eitzen credits this strategic shift with doubling the company's revenue multiple times and transitioning Snapbar from a regional startup to a worldwide tech business.

Seattle-Area Longevity Biomedical to Go Public via SPAC in Q2 2023, Raising $30M with $236M Valuation

Longevity Biomedical, formed by merging Seattle-area startups Cerevast Medical, NovoKera, and Aegeria Soft Tissue, plans to go public via a SPAC merger expected to close in Q2 2023, raising at least $30 million. The combined company targets healthspan extension with treatments for stroke, blindness, and soft-tissue reconstruction, and is valued at $236.2 million.

Seattle Biotech Myosana Raises $5M to Develop Advanced Gene Therapy for Duchenne Muscular Dystrophy

Myosana Therapeutics, a Seattle biotech co-founded by University of Washington researchers, raised $5 million to advance a novel gene therapy candidate targeting Duchenne muscular dystrophy (DMD). The company aims to develop a gene delivery platform that can handle larger DNA segments compared to current standard methods, potentially improving treatment options against DMD.

Seattle Startup Valid8 Financial Raises $1.25M Debt to Support Forensic Accounting in Major White-Collar Crime Cases

Seattle startup Valid8 Financial offers a forensic accounting platform used by lawyers, CPAs, and government agencies to analyze money flows in white-collar crime cases and financial disputes. Founded in 2017, Valid8 recently raised $1.25 million in debt financing and serves clients like law and CPA firms as well as six states for fraud investigations.

SafKan Health Raises $8M and Secures FDA Clearance for OtoSet Earwax Removal Device after Viral TikTok Success

Seattle-based SafKan Health has raised $8 million and received FDA clearance for its OtoSet device, which removes earwax through a combination of irrigation and suction and has gained viral attention on TikTok. The device aims to modernize earwax removal by being faster and easier to use than current clinical methods, and has been adopted by hundreds of clinics.

Century Therapeutics Cuts 25% Staff, Closes Seattle and Hamilton Sites, R&D Head Hyam Levitsky to Resign by Jan 31

Century Therapeutics is closing its Seattle hub and cutting 25% of its workforce, including a shutdown of its Hamilton, Ontario location, as it shifts priorities and extends its cash runway to 2026. The company’s president of R&D, Hyam Levitsky, plans to resign by January 31, and Century is de-prioritizing programs for glioblastoma and blood cancers.

People

See all 6

Online